2017-2021 Long Acting Injectable Anti-psychotic Market Trends and Forecasts Report

1
Global Long Acting Injectable Anti-psychotic
Market Size, Trends Forecasts (2017-2021)
Published April 2017 Pages 81 Price US 800
(Single User License)

• E-mail sales_at_marketreportsonline.com
• Tel [phone]

2
Global Long Acting Injectable Anti-psychotic
Market Size, Trends Forecasts (2017-2021)
Scope of the Report The report entitled Global
Long Acting Injectable Anti-psychotic Market
Size, Trends Forecasts (2017-2021), provides
analysis of the global injectable anti-psychotic
market, with detailed analysis of market size and
growth, and segmentation of the industry. The
report also includes a detailed regional analysis
of the long acting injectable anti-psychotic
market in the region of the US. Under competitive
landscape, different products in the long acting
injectable anti-psychotic market have been
compared on the basis of different parameters
such as dosing frequency, patent expiry,
injection sites, label, storage, needles and
available strengths. Also, a financial comparison
of long acting injectable market players in the
US has been done. Moreover, the report also
assesses the key opportunities in the market and
outlines the factors that are and will be driving
the growth of the industry. Growth of the overall
global long acting injectable anti-psychotic
market has also been forecasted for the years
2017-2021, taking into consideration the previous
growth patterns, the growth drivers and the
current and future trends. Johnson Johnson,
Eli Lily and Company, Alkermes Public Limited
Company and Lundbeck are some of the key players
operating in the global long acting injectable
anti-psychotic market, whose company profiling
has been done in the report. In this segment of
the report, business overview, financial overview
and business strategies of the companies are
provided. Complete report on long acting
injectable anti-psychotic industry spread across
70 pages with providing 4 company profiles with 3
tables and 28 figures is now available at
http//www.marketreportsonline.com/582443.html.
3
Global Long Acting Injectable Anti-psychotic
Market Size, Trends Forecasts (2017-2021)
Anti-psychotic refers to a class of medicine used
for the treatment of psychosis and various other
emotional and mental conditions. Psychosis
consist of delusions, hallucinations, paranoia
and disordered thought. It is a condition in
which a person experiences thought disorder and
personality changes. Long acting injectable
anti-psychotics are a sub type of antipsychotics
which were primarily developed to improve the
treatment of schizophrenia. The global long
acting injectable anti-psychotic market can be
studied on the basis of different products and on
the basis of prescription. These products are
different types of long acting injectable
anti-psychotic namely Invega Sustenna/ Trinza,
Risperdal Consta, Abilify Maintena, Zyprexa,
Aristada and many more. The global long acting
injectable anti-psychotic market is expected to
increase at a healthy rate during the forecast
period (2017-2021). The global long acting
injectable anti-psychotic market is supported by
various growth drivers, such as increasing cases
of schizophrenia, rising number of bipolar
disorder patients and non adherence to oral
anti-psychotic. However, side effect associated
with anti-psychotic and patent expiry of some of
the leading brands are some of the challenges
faced by the market. Aging dernography, grant of
approval to Trevicta in European Commission,
third party proprietary technologies and label
expansion of Abilify Maintena are some of the
latest trends in the global long acting
injectable anti-psychotic market. Order a copy
of this Global Long Acting Injectable
Anti-psychotic Market research report at USD 800
(Single User License) http//www.marketreportsonli
ne.com/contacts/purchase.php?name582443.
4
Global Long Acting Injectable Anti-psychotic
Market Size, Trends Forecasts (2017-2021)
Few Points from List of Charts Figure 1
Psychiatric Disorder Figure 2 Global
Anti-psychotic Market by Value 2011-2016 (US
Billion) Figure 3 Global Anti-psychotic Market
by Value 2017-2021 (US Billion) Figure 4
Global Anti-psychotic Market by Products
2016 Figure 5 Global Anti-psychotic Market by
Prescription 2016 Figure 6 Global Long Acting
Injectable Anti-psychotic Market by Value
2015-2021 (US Billion) Figure 7 Global Long
Acting Injectable Anti-psychotic Market Value by
Product 2016 Figure 8 Global Long Acting
Injectable Anti-psychotic Market Volume by
Products 2016 Figure 9 Global Long Acting
Injectable Anti-psychotic Market by Region
2016 Figure 10 Global Abilify Maintena Market by
Value 2015-2021 ( US Million) Figure 11 Global
Aristada Market by Value 2015-2021 (US
Million) Figure 12 Global Invega Sustenna Market
by Value 2015-2021 (US Billion) Figure 13
Global Risperdal Consta Market by Value
2015-2021(US Million) Figure 14 Global Zyprexa
Market by Value 2016-2021(US Million) Figure
15 Global Zyprexa Market by Region 2016 Figure
16 The US Long Acting Injectable Anti-psychotic
Market by Value 2016-2021 (US Billion) Figure
17 Schizophrenia Patients in the US2015-2025
(000) Figure 18 Bipolar Disorder Patients in
the US 2017-2025 (000) Figure 19 Global
Population (65 years and Above) 2011-2015
(Million) Figure 20 US Long Acting Injectable
Antipsychotic Market by Players 2016 Figure 21
Johnson Johnson Sales 2012-2016 (US
Billion) Explore More Latest Reports on
Pharmaceuticals Market at http//www.marketreports
online.com/cat/pharmaceuticals-market-research.htm
l.
5
Global Long Acting Injectable Anti-psychotic
Market Size, Trends Forecasts (2017-2021)
About Us MarketReportsOnline comprises of an
online library of 2,50,000 reports and in-depth
market research studies of over 5000 micro
markets. We provide 24/7 online and offline
support to our customers. Get in touch with us
for your needs of market research
reports. Contact Us Ritesh Tiwari UNIT no 802,
Tower no. 7, SEZ Magarpatta city, Hadapsar Pune,
Maharashtra, India Tel [phone] E-mail
sales_at_marketreportsonline.com